Fareva to grow its newly acquired biomanufacturing capabilities A leading third-party manufacturer in the small molecule active pharmaceutical ingredient (API) and finished formulation industry, Fareva entered the biologics CDMO sector last year, subsequently… read more

GSK and Vir seek EUA for monoclonal antibody to treat Covid-19 GlaxoSmithKline (GSK) and Vir Biotechnology have applied for emergency use authorization (EUA) from the US FDA for VIR-7831 (GSK4182136), an investigational dual-action… read more

Fujifilm Diosynth Biotechnologies’ Biologics Production Facility Expansion Japanese multinational conglomerate Fujifilm has made a capital investment of JPY100bn ($928m) for the expansion of its subsidiary Fujifilm Diosynth Biotechnologies’ (FDB) biologics production facility in… read more

Agenus Submits Balstilimab Biologics License Application to the U.S. FDA for Patients with Recurrent or Metastatic Cervical Cancer Immuno-oncology company Agenus Inc. has submitted a Biologics License Application (BLA) to the U.S. FDA… read more

BeiGene Gains Commercial Manufacturing Approval for Guangzhou Biologics Facility Biotechnology company BeiGene has announced approval from the China National Medical Products Administration (NMPA) to commence the manufacturing of tislelizumab, its anti-PD-1 antibody. This… read more

KM Biologics Announces Phase I Clinical Study Results of a Live Attenuated Tetravalent Dengue Vaccine (KD-382) KM Biologics Co., Ltd. (Headquarters: Kumamoto, Japan; CEO: Toshiaki Nagasato) announced the results of the Phase I… read more

AbbVie sells biologics plant to Pharmaron, fueling the China company's cell and gene therapy ambitions Roughly half a year after closing its $63 billion megamerger with Allergan, AbbVie is letting go of the… read more

UCI Health Creates New Delivery System For Monoclonal Antibodies In COVID-19 Patients Monoclonal antibodies are showing promise for improving outcomes for COVID-19 patients, but when a hospital is already beyond capacity, administering them… read more

WuXi Biologics to Acquire Pfizer China’s Biologics Manufacturing Facilities WuXi Biologics announced on March 17, 2021 that it has entered into an equity agreement with Pfizer China to acquire its biologics manufacturing facilities… read more

UCI Health Creates New Delivery System For Monoclonal Antibodies In COVID-19 Patients Monoclonal antibodies are showing promise for improving outcomes for COVID-19 patients, but when a hospital is already beyond capacity, administering them… read more